Pune, March 02, 2023 (GLOBE NEWSWIRE) -- Maximize Market research, a global Healthcare business consulting and research firm, has published a global intelligence report on the “Gene Therapy Market”. The report is a combination of primary and secondary data and the domain expert has analyzed the Gene Therapy Market from a global as well as a regional perspective. The total market opportunity for Gene Therapy Market was USD 6.21 Bn in 2021 and is expected to grow at a CAGR of 27.9 percent through the forecast period to reach USD 44.51 Bn by 2029.
| Market Size in 2021 | USD 6.21 Bn |
| Market Size in 2029 | USD 44.51 Bn |
| CAGR | 27.9 percent (2022-2029) |
| Forecast Period | 2022-2029 |
| Base Year | 2021 |
| Number of Pages | 250 |
| No. of Tables | 117 |
| No. of Charts and Figures | 114 |
| Segment Covered | Indication and Vector Type |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Request For Free Sample Report: https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market Scope and Research Methodology
The report provides a comprehensive analysis of the Gene Therapy Market by region, segment and competitive landscape. For understanding the global factors affecting the Gene Therapy Market, the report presents drivers, challenges, restraints and opportunities prevailing in the Gene Therapy Market. The report covers the current trends prevailing in the market along with estimations about future trends to help understand investors identify investment pockets and opportunities in the Gene Therapy Market.
The report is equipped with a competitive analysis of the Gene therapy Market players. Key players and new entrants in the Gene Therapy Market are listed together. The Gene Therapy Market was analyzed by region, revenue, financial status, portfolio, technological advancement adopted, social, social media presence, and mergers and acquisitions. The new entrants in Gene Therapy Market was researched for growth prospects and future business outlooks. The report acts as a guide for stakeholders, investors, market players and followers and new entrants with an overall view of the Gene Therapy Market for formulating investment approaches and marketing tactics. The bottom-up-up approach was used to estimate the Gene Therapy Market Size.
Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market Overview
Gene Therapy in the medical field focuses on the genetic modification of cells to produce a therapeutic effect on the disease by repairing or reconstructing defective genetic material. Gene therapy is a significant process used for certain disorders and additional potential medications discovered with new trends in the field of hematological diseases. DNA encodes a functional therapeutic gene to replace a mutated gene.
Gene Therapy Market Dynamics
Advancements in Gene therapies, desirable research goals to fight against degenerative illnesses, increasing cases of Cancer and other chronic diseases across the globe are the factors expected to boost the Gene Therapy Market growth. Gene therapy is used to treat various disorders and has been demonstrated to be effective. Gene Therapy Market growth is influenced by a strong product portfolio, high investment by the major market players, and new innovations in Gene therapy. Government support, commercial upstream manufacturing are the factors expected to influence the market growth with the support of regulations.
Get a Sample PDF Brochure: https://www.maximizemarketresearch.com/request-sample/85074
The adverse effect of traditional treatment methods like chemotherapy is being replaced with Gene Therapy. Increasing technological advancements in cellular and molecular biology in genomics research have contributed to the Gene Therapy Market growth.
Difficulties in development including safety and efficiency problems by the clinical study protocols, high prices of cell and gene therapy are the factors expected to hamper the Gene Therapy Market growth.
Gene Therapy Market Regional Insights
North American region is expected to dominate the global Gene Therapy Market over the forecast period. The region held the largest market share accounting for 55 percent in 2021. An increase in the number of insurance coverage, highly developed Research & Development institutes, and government funding is the factors expected to influence the regional Gene Therapy Market growth. Regulations for cellular treatment development and the presence of biopharmaceutical businesses are expected to drive market growth.
Purchase Report: https://www.maximizemarketresearch.com/checkout/?method=PayPal&reportId=85074&type=Single%20User
Asia Pacific region is expected to grow with a significant growth rate during the forecast period 2022-2029. Large spending by the healthcare sector for hospitals and dispensing medicines helps the Gene Therapy market to grow.
Gene Therapy Market Segmentation
By Indication:
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-cell Lymphoma
- ADA-SCID
- Melanoma (lesions)
- Beta-Thalassemia Major/SCD
- Head & Neck Squamous Cell Carcinoma
- Peripheral Arterial Disease
- Spinal Muscular Atrophy (SMA)
- Others
By Vector Type:
- Lentivirus
- AAV
- Retrovirus & gamma Retrovirus
- Modified Herpes Simplex Virus
- Adenovirus
- Non-viral Plasmid Vector
Gene Therapy Market Key Players Include
- REGENXBIO, Inc.
- Bayer
- Oxford BioMedica plc
- Dimension Therapeutics, Inc.
- Bristol-Myers Squibb Company
- SANOFI
- Applied Genetic Technologies Corp
- F. Hoffmann-La Roche Ltd.
- Bluebird Bio, Inc.
- Novartis AG
- Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
- UniQure N.V.
- Shire Plc;
- Cellectis S.A.
- Sangamo Therapeutics, Inc.
- Orchard Therapeutics
- Gilead Lifesciences, Inc.
- Benitec Biopharma Ltd.
- Sibiono GeneTech Co., Ltd.
- Shanghai Sunway Biotech Co., Ltd
- Gensight Biologics S.A.
- Transgene
- Calimmune, Inc
- Epeius Biotechnologies Corp
- Astellas Pharma, Inc
- American Gene Technologies
- BioMarin Pharmaceuticals, Inc.
- Human Stem Cell Institute
- Spark Therapeutics LLC
- GlaxoSmithKline
- Voyager Therapeutics
Key questions answered in the Gene Therapy Battery Market are:
- What is Gene Therapy Battery?
- What was the Gene Therapy market size in 2021?
- What is the growth rate of the Gene Therapy Market?
- Which are the factors expected to drive the Gene Therapy market growth?
- Which segment dominated the Gene Therapy market growth?
- What is the demand pattern for the Gene Therapy market?
- Which region held the largest share of the Gene Therapy market?
- Who are the key players in the Gene Therapy market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size & Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by Indication, Vector Type and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Cell and Gene Therapy Manufacturing Market: The total market size was expected to reach USD 22.73 Bn by 2029 from USD 5.25 Bn in 2021 at a CAGR of 20.10 percent during the forecast period. Rising prevalence of cancer and other target diseases, high spending on R&D activities and increased collaborations and agreements between pharmaceuticals are factors expected to drive the market growth.
Gene Synthesis Market: The total Market size was valued at USD 1.60 Bn in 2021 and is expected to grow at 11 percent CAGR through 2021 to 2029 to reach USD 3.70 Bn by 2029. Higher R&D activities in the field of genomics and next-generation sequencing are expected to drive market growth.
Gene Delivery Technologies Market: The total size was valued at USD 3.59 Bn in 2021 and is expected to grow at 12.2 percent of CAGR through 2021 to 2029, reaching nearly USD 9.01 Bn by the end of the forecast period. Rising Nanotechnology and physical technology are expected to influence market growth.
Autologous Cell Therapy Market: The total market size was valued at USD 5.5 Bn in 2021 and is expected to grow by 21.5 percent CACR from 2022 to 2029, reaching nearly USD 26.1 Bn by 2029. A growing number of diseases, Government support and initiatives and Increased Technological Advancement are the factors expected to influence market growth.
Cell Therapy Market: The market size was valued at USD 8.92 Bn in 2021 and is expected to reach USD 25.47 Bn by 2029, at a CAGR of 14.00 percent during the forecast period 2022-2029. The increasing number of chronic diseases and new regenerative technologies are expected to drive market growth.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
